EastWest Bioscience Inc.
HBOSF
OTC PK
| 04/30/2022 | 01/31/2022 | 10/31/2021 | 07/31/2021 | 04/30/2021 | |
|---|---|---|---|---|---|
| Revenue | 230.90K | 334.00K | 428.00K | 487.30K | 573.40K |
| Total Other Revenue | 376.20K | 317.30K | 309.30K | 316.40K | 293.70K |
| Total Revenue | 607.10K | 651.20K | 737.30K | 803.80K | 867.20K |
| Cost of Revenue | 234.60K | 281.40K | 354.70K | 396.50K | 468.00K |
| Gross Profit | 372.60K | 369.90K | 382.60K | 407.20K | 399.10K |
| SG&A Expenses | 2.19M | 2.21M | 1.89M | 1.72M | 1.13M |
| Depreciation & Amortization | 83.70K | 88.30K | 90.70K | 93.10K | 96.80K |
| Other Operating Expenses | 6.80K | 6.80K | -5.50K | -3.70K | 13.90K |
| Total Operating Expenses | 2.52M | 2.59M | 2.34M | 2.21M | 1.71M |
| Operating Income | -1.92M | -1.94M | -1.61M | -1.41M | -845.00K |
| Income Before Tax | -27.30K | 294.90K | -1.52M | -1.30M | -730.80K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.03 | 0.29 | -1.52 | -1.30 | -0.73 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 87.20K | 87.20K | 87.20K | 18.20K | -- |
| Net Income | 59.80K | 382.00K | -1.43M | -1.28M | -730.80K |
| EBIT | -1.92M | -1.94M | -1.61M | -1.41M | -845.00K |
| EBITDA | -1.83M | -1.85M | -1.52M | -1.32M | -748.30K |
| EPS Basic | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 395.71M | 389.79M | 383.72M | 378.96M | 369.10M |
| Average Diluted Shares Outstanding | 395.71M | 389.79M | 383.72M | 378.96M | 369.10M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
